Centre for Human Immunology, University of Western Ontario London, ON, Canada.
Front Microbiol. 2011 Jul 22;2:159. doi: 10.3389/fmicb.2011.00159. eCollection 2011.
Cationic antimicrobial peptides and polymyxins are a group of naturally occurring antibiotics that can also possess immunomodulatory activities. They are considered a new source of antibiotics for treating infections by bacteria that are resistant to conventional antibiotics. Members of the genus Burkholderia, which includes various human pathogens, are inherently resistant to antimicrobial peptides. The resistance is several orders of magnitude higher than that of other Gram-negative bacteria such as Escherichia coli, Salmonella enterica, or Pseudomonas aeruginosa. This review summarizes our current understanding of antimicrobial peptide and polymyxin B resistance in the genus Burkholderia. These bacteria possess major and minor resistance mechanisms that will be described in detail. Recent studies have revealed that many other emerging Gram-negative opportunistic pathogens may also be inherently resistant to antimicrobial peptides and polymyxins and we propose that Burkholderia sp. are a model system to investigate the molecular basis of the resistance in extremely resistant bacteria. Understanding resistance in these types of bacteria will be important if antimicrobial peptides come to be used regularly for the treatment of infections by susceptible bacteria because this may lead to increased resistance in the species that are currently susceptible and may also open up new niches for opportunistic pathogens with high inherent resistance.
阳离子抗菌肽和多粘菌素属于一组天然存在的抗生素,也具有免疫调节活性。它们被认为是治疗对抗生素具有耐药性的细菌感染的新型抗生素来源。伯克霍尔德氏菌属的成员包括各种人类病原体,对抗菌肽具有固有抗性。这种抗性比其他革兰氏阴性细菌(如大肠杆菌、沙门氏菌或铜绿假单胞菌)高出几个数量级。本文综述了我们目前对伯克霍尔德氏菌属中抗菌肽和多粘菌素 B 耐药性的认识。这些细菌具有主要和次要的耐药机制,将详细描述。最近的研究表明,许多其他新兴的革兰氏阴性机会性病原体也可能对抗菌肽和多粘菌素固有耐药,我们提出伯克霍尔德氏菌属是研究极耐药细菌耐药性分子基础的模型系统。如果抗菌肽开始常规用于治疗敏感细菌的感染,了解这些类型细菌的耐药性将非常重要,因为这可能导致目前敏感的物种的耐药性增加,并且也可能为具有高固有耐药性的机会性病原体开辟新的生态位。